Form 8-K - Current report:
SEC Accession No. 0001140361-21-030721
Filing Date
2021-09-09
Accepted
2021-09-09 06:05:30
Documents
21
Period of Report
2021-09-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10028789_8k.htm   iXBRL 8-K 28605
2 EXHIBIT 99.1 brhc10028789_ex99-1.htm EX-99.1 17474
6 brhc10028789_ex99-1slide1.jpg GRAPHIC 116763
7 brhc10028789_ex99-1slide2.jpg GRAPHIC 219934
8 brhc10028789_ex99-1slide3.jpg GRAPHIC 214382
9 brhc10028789_ex99-1slide4.jpg GRAPHIC 146192
10 brhc10028789_ex99-1slide5.jpg GRAPHIC 137010
11 brhc10028789_ex99-1slide6.jpg GRAPHIC 72950
12 brhc10028789_ex99-1slide7.jpg GRAPHIC 148695
13 brhc10028789_ex99-1slide8.jpg GRAPHIC 163715
  Complete submission text file 0001140361-21-030721.txt   1868936

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA btx-20210909.xsd EX-101.SCH 3929
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE btx-20210909_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btx-20210909_pre.xml EX-101.PRE 16047
14 EXTRACTED XBRL INSTANCE DOCUMENT brhc10028789_8k_htm.xml XML 4394
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 211243434
SIC: 2834 Pharmaceutical Preparations